Literature DB >> 1875058

Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells.

C O Zachariae1, K Thestrup-Pedersen, K Matsushima.   

Abstract

The capacity of human melanocytes and melanoma cells to produce IL-8 and monocyte chemotactic and activating factor (MCAF) was investigated. Melanocytes expressed mRNA for IL-8 and MCAF, when stimulated with either IL-1 alpha or TNF alpha, but not when stimulated with IL-6, IFN gamma, or LPS alone. IL-8 and MCAF could be induced in a dose-dependent fashion with doses as low as 0.1 ng/ml TNF alpha and 0.5 ng/ml IL-1 alpha. IL-8 and MCAF mRNA were rapidly expressed and peaked between 2 and 4 h for IL-8 and between 4 and 8 h for MCAF. This correlated well with the accumulation of IL-8 antigen as measured by a radioimmunoassay. Supernatants from melanocyte cultures stimulated with either IL-1 alpha or TNF alpha and separated on a heparin-Sepharose column became positive for neutrophil and monocyte chemotactic activity in a dose- and time-dependent fashion. When IFN gamma was added to melanocyte cultures stimulated with suboptimal doses of TNF alpha there was a synergistic increase in secreted IL-8 protein and monocyte chemotactic activity. These data provide further evidence for the possible role of melanocytes in the initiation of an inflammatory reaction. Three different malignant melanoma cell lines stimulated with either TNF alpha or IL-1 alpha expressed IL-8 mRNA, but not mRNA for MCAF. The IL-8 mRNA signal corresponded well with the amount of secreted IL-8 protein. These data suggest that IL-8 and MCAF may play a role in growth regulation and spreading of melanomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875058     DOI: 10.1111/1523-1747.ep12481934

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

Review 1.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

Review 2.  The skin as an immune organ.

Authors:  J K Salmon; C A Armstrong; J C Ansel
Journal:  West J Med       Date:  1994-02

3.  Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation.

Authors:  Margaret J Slattery; Shile Liang; Cheng Dong
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-15       Impact factor: 4.249

4.  Neutrophils influence melanoma adhesion and migration under flow conditions.

Authors:  Margaret J Slattery; Cheng Dong
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

5.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.

Authors:  B Stein; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

6.  Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.

Authors:  J E Crabtree; J I Wyatt; L K Trejdosiewicz; P Peichl; P H Nichols; N Ramsay; J N Primrose; I J Lindley
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

7.  Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.

Authors:  Tariq Hamid; Mohammed T Malik; Sham S Kakar
Journal:  Mol Cancer       Date:  2005-01-13       Impact factor: 27.401

Review 8.  Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?

Authors:  Mario Rotondi; Francesca Coperchini; Francesco Latrofa; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-21       Impact factor: 5.555

Review 9.  Melanogenesis Connection with Innate Immunity and Toll-Like Receptors.

Authors:  Saaya Koike; Kenshi Yamasaki
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

10.  Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.

Authors:  Haiyan Yu; Jianping Cen; Xiaoxia Lin; Hao Cheng; Oliver Seifert
Journal:  Immun Inflamm Dis       Date:  2021-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.